ClinicalTrials.gg
Active, not recruitingNCT06359249Updated Aug 19, 2026

Do the Symptoms of Chronic Constipation Improve With a Primary Care Programme Based on Behavioural Re-education and Abdominal Massage?

An interventional study of change of habits and change of habits + auto abdominal massage in Constipation Chronic Idiopathic, sponsored by Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina. Active, not recruiting at 1 site in Spain. Open to participants aged 18 Years to 75 Years. Per ClinicalTrials.gov, last updated 2026-08-19.

Sponsored by Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina · Not applicable, Interventional, and Treatment

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
45
Allocation
Randomized
Ages
18 Years to 75 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 29 studies in Pelvic Floor Disorders with a site in Spain — 9 open to participants now, 10 under way, none of them phase 3. Pelvic Floor Disorders · Spain.

Planned enrollment
20th of 26
45 · median 68
Started
2024
with 4 others
No phase
25 of 29
7 open now
Registered
19th of 29
by date
Lead sponsor
1 of 29
Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina

Among the 29 studies in Pelvic Floor Disorders with a site in Spain, this one is the 20th largest by planned enrollment of the 26 interventional ones that give a count, is one of 5 that started in 2024, is one of 25 with no phase, and was the 19th registered.

Pelvic Floor Disorders

212 studies on the registry are indexed under Pelvic Floor Disorders; 46 are open to participants now.

Browse Pelvic Floor Disorders studies →

Open to participants now

9 of the 29 studies in Pelvic Floor Disorders with a site in Spain are open now. Recruiting first, the newest first:

4 more — sign in →

All 9 open studies →

A study can be open while its sites in Spain have not opened yet or have stopped. Only those recruiting at a site in Spain →

Who these studies take

Of the 27 Pelvic Floor Disorders studies recruiting now, 17 (63%) set no upper age limit and 10 (37%) stop at 75 or younger; none take children under 18; 9 take healthy volunteers.

This study: 18 Years to 75 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 29 studies in Pelvic Floor Disorders with a site in Spain, or all of them as a file.
02

Study summary

Constipation is one of the most common digestive problems in today's society. In Spain, it is estimated that this condition affects between 12% and 20% of the population, being more frequent in women, contributing considerably to the quality of life, to the increase of medical visits and to high costs for the health system. The objectives of the study are to reduce the rate of constipation and laxative use in the short term with a structured rehabilitation programme consisting of abdominal massage therapy and behavioural re-education, to improve the quality of life of these patients, and to assess whether the proposed treatment is effective in the short and medium term.

Read the detailed description

Background: Constipation is one of the most common digestive problems in today's society. In Spain, it is estimated that this condition affects between 12% and 20% of the population, being more frequent in women, contributing considerably to the quality of life, to the increase of medical visits and to high costs for the health system. The objectives of the study are to reduce the rate of constipation and laxative use in the short term with a structured rehabilitation programme consisting of abdominal massage therapy and behavioural re-education, to improve the quality of life of these patients, and to assess whether the proposed treatment is effective in the short and medium term.

Method: Randomised clinical trial. Participants: people with constipation in the region of L'Anoia, Catalonia. There will be 3 groups: the control group (CG), behavioural intervention group (BIG) and behavioural intervention and massage group (BIMG). Constipation will be assessed with the Bristol scale, Rome IV Criteria and the number of laxatives; and quality of life with the CVE-20 Questionnaire.

Participants will be proposed from Primary Care Centres in the region of L'Anoia, Catalonia, Spain.

Inclusion criteria:

  • Having been diagnosed with primary constipation using Rome IV Criteria(11), of more than three months' duration.
  • Understanding Catalan, Spanish or English.

Exclusion criteria:

  • Having constipation secondary to neurogenic, metabolic, endocrine or postoperative diseases.
  • Having constipation secondary to medication for other pathologies, the medication list for which can be found in the annex.
  • Having any type of open abdominal and/or anal wound, such as a recent abdominal scar or anal fissure.
  • Meeting any absolute contraindication criteria for the use of abdominal massage therapy, such as an unstable fracture requiring absolute rest and immobilisation, pregnancy or active oncological procedures.
  • Suffering from some type of cognitive, psychiatric or neurological alteration that does not allow to understand the project.

Discussion: Research is needed on conservative, non-pharmacological treatment to try to reduce one of the main conditions affecting public health, and thus reduce the possible illnesses associated with constipation and reduce costs to the health system.

03

Conditions studied

  • Constipation Chronic Idiopathic

Keywords

  • Chronic constipation
  • abdominal massage
  • proctologic disease
  • pelvic floor disorders
  • physical therapy
04

Who can participate

Ages eligible
18 Years to 75 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Having been diagnosed with primary constipation using Rome IV Criteria(11), of more than three months' duration.
  • Understanding Catalan, Spanish or English.

Exclusion criteria

Exclusion Criteria:

  • Having constipation secondary to neurogenic, metabolic, endocrine or postoperative diseases.

    • Having constipation secondary to medication for other pathologies, the medication list for which can be found in the annex.
    • Having any type of open abdominal and/or anal wound, such as a recent abdominal scar or anal fissure.
    • Meeting any absolute criteria for the use of abdominal massage therapy, such as an unstable fracture requiring absolute rest and immobilisation, pregnancy or active oncological procedures.
    • Suffering from some type of cognitive, psychiatric or neurological alteration that does not allow to understand the project.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
45 participants (estimated)

Study arms

  • No intervention
    Control group

    Habitual treatment

  • Experimental
    behavioural intervention group

    Conductual treatment

    Behavioral: change of habits

  • Experimental
    behavioural intervention and massage group

    Conductual and abdominal massage treatment

    Other: change of habits + auto abdominal massage

Interventions

  • Behavioralchange of habits

    change of habits

  • Otherchange of habits + auto abdominal massage

    change of habits + auto abdominal massage

06

What researchers measure

Primary outcomes

  1. Degree of constipation

    Degree of constipation with Rome IV Criteria

    Time frame: Before intervention (Tpre), Day 0, Month 3, Month 6

  2. Stool characteristics

    Stool characteristics with the Bristol Scale

    Time frame: Day 0, Month 3, Month 6

  3. Quality of life focused on patients with constipation

    Quality of life focused on patients with constipation with the CVE-20 questionnaire from an emotional, physical and social viewpoint.

    Time frame: Day 0, Month 3, Month 6

  4. The number of laxatives taken by each participant

    The number of laxatives taken by each participant with an accounting schedule.

    Time frame: Month 3, Month 6

Secondary outcomes

  1. Sex

    Male / Female

    Time frame: Before intervention (Tpre)

  2. Age

    Measured in years

    Time frame: Before intervention (Tpre)

  3. Previous conditions

    Baseline characteristics, including the prevalence of relevant comorbidities and cardiovascular risk factors, such as hypertension, diabetes mellitus, smoking status, obesity, and other clinically relevant conditions. The proportion of participants presenting each comorbidity at baseline will be assessed.

    Time frame: Before intervention (Tpre)

  4. Level of physical activity

    Mesured with the VREM questionnaire.

    Time frame: Day 0, Month 3, Month 6

07

Study locations

1 site
  • Cristina Segura Bayona
    Igualada, Barcelona 08700, Spain
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Mar 2024 (actual). Primary completion is estimated for Dec 2026, 33 months after the start.

Of 100 non-industry interventional studies with no phase under Pelvic Floor Disorders, half reached primary completion within 18 months of starting (the median), counting those still running; a quarter within 7 and three quarters within 31. This study's planned 33 months is above that.

Counting every sponsor, half of 106 studies reached it within 17 months; a quarter within 7 and three quarters within 31.

How these figures are worked out, and which studies are left out of them.

Registered
Mar 18, 2024
First posted
Apr 11, 2024
StartActual
Mar 1, 2024
Primary completionEst.
Dec 28, 2026
CompletionEst.
Dec 28, 2026
Last update
Aug 19, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Aug 19, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06359249
Collaborators
Universitat de Vic
Responsible party
Sponsor
First posted
Apr 11, 2024
Start date
Mar 1, 2024
Primary completion
Dec 28, 2026 (estimated)
Completion
Dec 28, 2026 (estimated)
Last update
Aug 19, 2026

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in Sep 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion